Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na(+)/K(+)-ATPase-density

PURPOSE: Tumour blood flow (TBF) is a crucial determinant of cancer growth. Recently, we validated Rubidium-82 ((82)Rb) positron emission tomography (PET) for TBF measurement in prostate cancer (PCa) and found TBF and cancer aggressiveness positively correlated. The aims of the present study were to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Nucl Med Mol Imaging
Autori principali: Jochumsen, Mads Ryø, Sörensen, Jens, Pedersen, Bodil Ginnerup, Nyengaard, Jens Randel, Krag, Søren Rasmus Palmelund, Frøkiær, Jørgen, Borre, Michael, Bouchelouche, Kirsten, Tolbod, Lars Poulsen
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7835182/
https://ncbi.nlm.nih.gov/pubmed/32808078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-04998-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi